A risk assessment of atrazine use in California: human health and ecological aspects†
TL;DR: It was concluded that N-nitrosotriazines are unlikely to play a significant role in triazine-induced rat mammary gland tumors, and dietary exposure to atrazine is therefore extremely unlikely to result in human health hazard.
Abstract: A risk assessment of the triazine herbicide atrazine has been conducted by first analyzing the toxicity database and subsequently estimating exposure. Margins of safety (MOS) were then calculated. Toxicity was assessed in animal studies and exposure was estimated from occupational and dietary sources. In acute toxicity studies, atrazine caused developmental toxicity in the rabbit [no observed effect level (NOEL) 5 mg kg(-1) day(-1)] and cardiotoxicity in a dog chronic study (NOEL 0.5 mg kg(-1) day(-1)); cancer (mammary glands) resulted from lifetime exposure. The mammary tumors, which occurred specifically in female Sprague-Dawley rats, were malignant, increased in a dose-dependent manner and were also observed with other, related triazines. Evidence for a genotoxic basis for these tumors was either equivocal or negative. Triazines have been shown to be clastogenic in Chinese hamster ovary cells, in vitro, but without showing a convincing dose/response relationship. Atrazine can be converted into genotoxic N-nitrosoatrazine in the environment or the digestive system, suggesting that N-nitrosamines derived from triazines could be oncogenic. However, it was concluded that N-nitrosotriazines are unlikely to play a significant role in triazine-induced rat mammary gland tumors. An endocrine basis for the mammary tumors, involving premature aging of the female SD rat reproductive system, has been proposed. A suppression of the luteinizing hormone surge during the estrus cycle by atrazine leads to the maintenance of elevated blood levels of 17beta-estradiol (E2) and prolactin. The mechanism for tumor development may include one or more of the following: the induction of aromatase (CYP19) and/or other P450 oxygenases, an antagonist action at the estrogen feedback receptor in the hypothalamus, an agonist action at the mammary gland estrogen receptor or an effect on adrenergic neurons in the hypothalamic-pituitary pathway. None of these has been excluded as a target because there has been a lack of a rigorous attempt to address the mechanism of action for mammary tumors at the molecular level. The potential occupational exposure to atrazine was assessed during mixing, loading and application. Absorbed daily dosage values were 1.8-6.1 microg kg(-1) day(-1). The MOS values (animal NOEL/human exposure) for short-term (acute) exposure were 820-2800. Longer-term occupational exposure and risk were also calculated. Detectable crop residues are generally absent at harvest. Theoretical calculations of acute dietary exposure used tolerance levels, along with secondary residues, and water, for which there is a maximum contamination level; atrazine plus the three main chlorotriazine metabolites were combined. MOS values were above 2000 for all population subgroups. Dietary exposure to atrazine is therefore extremely unlikely to result in human health hazard. Recent publications have reported a possible feminization of frogs, measured in laboratory and field studies. This is assumed to be due to the induction of aromatase, but no measurements of enzyme activity have been reported. In field studies, the water bodies with the greatest numbers of deformed frogs sometimes had the lowest concentrations of atrazine. Other studies have also cast doubt on the feminization theory, except perhaps at very high levels of atrazine. Epidemiology studies have investigated the possibility that atrazine may result in adverse effects in humans. Although some studies have claimed that atrazine exposure results in an elevated risk of prostate cancer, the published literature is inconclusive with respect to cancer incidence.
Citations
More filters
TL;DR: A much more complete understanding of the endocrine principles by which EDCs act, including nonmonotonic dose-responses, low-dose effects, and developmental vulnerability, can be much better translated to human health.
Abstract: The Endocrine Society's first Scientific Statement in 2009 provided a wake-up call to the scientific community about how environmental endocrine-disrupting chemicals (EDCs) affect health and disease. Five years later, a substantially larger body of literature has solidified our understanding of plausible mechanisms underlying EDC actions and how exposures in animals and humans-especially during development-may lay the foundations for disease later in life. At this point in history, we have much stronger knowledge about how EDCs alter gene-environment interactions via physiological, cellular, molecular, and epigenetic changes, thereby producing effects in exposed individuals as well as their descendants. Causal links between exposure and manifestation of disease are substantiated by experimental animal models and are consistent with correlative epidemiological data in humans. There are several caveats because differences in how experimental animal work is conducted can lead to difficulties in drawing broad conclusions, and we must continue to be cautious about inferring causality in humans. In this second Scientific Statement, we reviewed the literature on a subset of topics for which the translational evidence is strongest: 1) obesity and diabetes; 2) female reproduction; 3) male reproduction; 4) hormone-sensitive cancers in females; 5) prostate; 6) thyroid; and 7) neurodevelopment and neuroendocrine systems. Our inclusion criteria for studies were those conducted predominantly in the past 5 years deemed to be of high quality based on appropriate negative and positive control groups or populations, adequate sample size and experimental design, and mammalian animal studies with exposure levels in a range that was relevant to humans. We also focused on studies using the developmental origins of health and disease model. No report was excluded based on a positive or negative effect of the EDC exposure. The bulk of the results across the board strengthen the evidence for endocrine health-related actions of EDCs. Based on this much more complete understanding of the endocrine principles by which EDCs act, including nonmonotonic dose-responses, low-dose effects, and developmental vulnerability, these findings can be much better translated to human health. Armed with this information, researchers, physicians, and other healthcare providers can guide regulators and policymakers as they make responsible decisions.
1,423 citations
TL;DR: This review aims to provide a comprehensive overview of the state of knowledge regarding the mechanisms by which chemicals interfere with the function of steroidogenic enzymes in various tissues and organisms.
452 citations
Cites result from "A risk assessment of atrazine use i..."
...…rat Leydig cells in culture, TCDD (0.2 or 2 ng/ml; 0.6 and 6nM) was found to reduce CYP11A expression in rat Leydig cells by impairing the ability of hCG to increase intracellular cAMP levels (Gammon et al., 2005), an effect which is fairly consistent with the observations by Moore et al. (1991)....
[...]
...6 and 6nM) was found to reduce CYP11A expression in rat Leydig cells by impairing the ability of hCG to increase intracellular cAMP levels (Gammon et al., 2005), an effect which is fairly consistent with the observations by Moore et al....
[...]
TL;DR: The central theory that environmentally relevant concentrations of atrazine affect reproduction and/or reproductive development in fish, amphibians, and reptiles is not supported by the vast majority of observations.
Abstract: The herbicide atrazine is widely used in agriculture for the production of corn and other crops. Because of its physical and chemical properties, atrazine is found in small concentrations in surface waters—habitats for some species. A number of reports on the effects of atrazine on aquatic vertebrates, mostly amphibians, have been published, yet there is inconsistency in the effects reported, and inconsistency between studies in different laboratories. We have brought the results and conclusions of all of the relevant laboratory and field studies together in this critical review and assessed causality using procedures for the identification of causative agents of disease and ecoepidemiology derived from Koch’s postulates and the Bradford‐Hill guidelines. Based on a weight of evidence analysis of all of the data, the central theory that environmentally relevant concentrations of atrazine affect reproduction and/or reproductive development in fish, amphibians, and reptiles is not supported by the vast majority of observations. The same conclusions also hold for the supporting theories such as induction of aromatase, the enzyme that converts testosterone to estradiol. For other responses, such as immune function, stress endocrinology, parasitism, or population-level effects, there are no indications of effects or there is such a paucity of good data that definitive conclusions cannot be made.
239 citations
Cites background from "A risk assessment of atrazine use i..."
...No effects on sex ratios in mammals were reported in multigeneration studies (U.S. EPA, 2000, Gammon et al., 2005)....
[...]
...Considerable research on the mechanism of this response has been conducted and was recently reviewed (Gammon et al., 2005, Cooper et al., 2007)....
[...]
...As has been pointed out (Gammon et al., 2005), there was no consistent response of gonadal abnormalities to concentration of atrazine....
[...]
TL;DR: It is suggested that long-term exposure to the herbicide ATZ might contribute to the development of insulin resistance and obesity, particularly where a high-fat diet is prevalent.
Abstract: There is an apparent overlap between areas in the USA where the herbicide, atrazine (ATZ), is heavily used and obesity-prevalence maps of people with a BMI over 30. Given that herbicides act on photosystem II of the thylakoid membrane of chloroplasts, which have a functional structure similar to mitochondria, we investigated whether chronic exposure to low concentrations of ATZ might cause obesity or insulin resistance by damaging mitochondrial function. Sprague-Dawley rats (n = 48) were treated for 5 months with low concentrations (30 or 300 microg kg(-1) day(-1)) of ATZ provided in drinking water. One group of animals was fed a regular diet for the entire period, and another group of animals was fed a high-fat diet (40% fat) for 2 months after 3 months of regular diet. Various parameters of insulin resistance were measured. Morphology and functional activities of mitochondria were evaluated in tissues of ATZ-exposed animals and in isolated mitochondria. Chronic administration of ATZ decreased basal metabolic rate, and increased body weight, intra-abdominal fat and insulin resistance without changing food intake or physical activity level. A high-fat diet further exacerbated insulin resistance and obesity. Mitochondria in skeletal muscle and liver of ATZ-treated rats were swollen with disrupted cristae. ATZ blocked the activities of oxidative phosphorylation complexes I and III, resulting in decreased oxygen consumption. It also suppressed the insulin-mediated phosphorylation of Akt. These results suggest that long-term exposure to the herbicide ATZ might contribute to the development of insulin resistance and obesity, particularly where a high-fat diet is prevalent.
207 citations
Cites background from "A risk assessment of atrazine use i..."
...However, a toxicological report has shown that acute occupational or dietary exposure of humans to ATZ was in the range of 0.2‐90 mg kg21 day21, and the annual average exposure (chronic) was between 0.046 and 0.286 mg kg21 day21 [ 48 ]....
[...]
TL;DR: The nanoparticle systems developed offer a useful means of controlling agricultural weeds, while at the same time reducing the risk of harm to the environment and human health.
196 citations
References
More filters
TL;DR: In this article, a cell comprising an estrogen receptor beta (ER beta ), AP1 proteins, and a construct comprising a promoter comprising an AP1 site which regulates expression of a first reporter gene is contacted with the test compound and changes in expression levels of the reporter gene are detected indicating whether the test compounds activate transcription, inactivate transcription or have no effect at the AP1 sites.
Abstract: This invention provides methods of screening test compounds for the ability to activate or inhibit estrogen receptor beta (ER beta ) mediated gene activation at an AP1 site. In particular, the methods involve providing a cell comprising an estrogen receptor beta (ER beta ), AP1 proteins, and a construct comprising a promoter comprising an AP1 site which regulates expression of a first reporter gene. The cell is contacted with the test compound and changes in expression levels of the reporter gene are detected indicating whether the test compounds activate transcription, inactivate transcription or have no effect at the AP1 site.
2,175 citations
TL;DR: It is hypothesize that atrazine induces aromatase and promotes the conversion of testosterone to estrogen and likely explains the demasculinization of the male larynx and the production of hermaphrodites.
Abstract: Atrazine is the most commonly used herbicide in the U.S. and probably the world. It can be present at several parts per million in agricultural runoff and can reach 40 parts per billion (ppb) in precipitation. We examined the effects of atrazine on sexual development in African clawed frogs (Xenopus laevis). Larvae were exposed to atrazine (0.01–200 ppb) by immersion throughout larval development, and we examined gonadal histology and laryngeal size at metamorphosis. Atrazine (>0.1 ppb) induced hermaphroditism and demasculinized the larynges of exposed males (>1.0 ppb). In addition, we examined plasma testosterone levels in sexually mature males. Male X. laevis suffered a 10-fold decrease in testosterone levels when exposed to 25 ppb atrazine. We hypothesize that atrazine induces aromatase and promotes the conversion of testosterone to estrogen. This disruption in steroidogenesis likely explains the demasculinization of the male larynx and the production of hermaphrodites. The effective levels reported in the current study are realistic exposures that suggest that other amphibian species exposed to atrazine in the wild could be at risk of impaired sexual development. This widespread compound and other environmental endocrine disruptors may be a factor in global amphibian declines.
1,130 citations
TL;DR: In this paper, an expert panel was convened to conduct a comprehensive aquatic ecological risk assessment based on several newly suggested procedures and included exposure and hazard subcomponents as well as the overall risk assessment.
Abstract: The triazine herbicide atrazine (2-chloro-4-ethylamino-6-isopropyl-amino-s-triazine) is one of the most used pesticides in North America. Atrazine is principally used for control of certain annual broadleaf and grass weeds, primarily in corn but also in sorghum, sugarcane, and, to a lesser extent, other crops and landscaping. Atrazine is found in many surface and ground waters in North America, and aquatic ecological effects are a possible concern for the regulatory and regulated communities. To address these concerns an expert panel (the Panel) was convened to conduct a comprehensive aquatic ecological risk assessment. This assessment was based on several newly suggested procedures and included exposure and hazard subcomponents as well as the overall risk assessment. The Panel determined that use of probabilistic risk assessment techniques was appropriate. Here, the results of this assessment are presented as a case study for these techniques. The environmental exposure assessment concentrated on monitoring data from Midwestern watersheds, the area of greatest atrazine use in North America. This analysis revealed that atrazine concentrations rarely exceed 20 μg/L in rivers and streams that were the main focus of the aquatic ecological risk assessment. Following storm runoff, biota in lower-order streams may be exposed to pulses of atrazine greater than 20 μg/L, but these exposures are short-lived. The assessment also considered exposures in lakes and reservoirs. The principal data set was developed by the U.S. Geological Survey, which monitored residues in 76 Midwestern reservoirs in 11 states in 1992-1993. Residue concentrations in some reservoirs were similar to those in streams but persisted longer. Atrazine residues were widespread in reservoirs (92% occurrence), and the 90th percentile of this exposure distribution for early June to July was about 5 μg/L. Mathematical simulation models of chemical fate were used to generalize the exposure analysis to other sites and to assess the potential effects of reduction in the application rates. Models were evaluated, modified, and calibrated against available monitoring data to validate that these models could predict atrazine runoff. PRZM-2 overpredicted atrazine concentrations by about an order of magnitude, whereas GLEAMS underpredicted by a factor of 2 to 5. Thus, exposure models were not used to extrapolate to other regions of atrazine use in this assessment. The effects assessment considered both freshwater and saltwater toxicity test results. Phytoplankton were the most sensitive organisms, followed, in decreasing order of sensitivity, by macrophytes, benthic invertebrates, zooplankton, and fish. Atrazine inhibits photophosphorylation but typically does not result in lethality or permanent cell damage in the short term. This characteristic of atrazine required a different model than typically used for understanding the potential impact in aquatic systems, where lethality or nonreversible effects are usually assumed. In addition, recovery of phytoplankton from exposure to 5 to 20 μg/L atrazine was demonstrated. In some mesocosm field experiments, phytoplankton and macrophytes were reduced after atrazine exposures greater than 20 μg/L. However, populations were quickly reestablished, even while atrazine residues persisted in the water. Effects in field studies were judged to be ecologically important only at exposures of 50 μg/L or greater. Mesocosm experiments did not reveal disruption of either ecosystem structure or function at atrazine concentrations typically encountered in the environment (generally 5 μg/L or less). Based on an integration of laboratory bioassay data, field effects studies, and environmental monitoring data from watersheds in high-use areas in the Midwestern United States, the Panel concluded that atrazine does not pose a significant risk to the aquatic environment. Although some inhibitory effects on algae, phytoplankton, or macrophyte production may occur in small streams vulnerable to agricultural runoff, these effects are likely to be transient, and quick recovery of the ecological system is expected. A subset of surface waters, principally small reservoirs in areas with intensive use of atrazine, may be at greater risk of exposure to atrazine. Therefore, it is recommended that site-specific risk assessments be conducted at these sites to assess possible ecological effects in the context of the uses to which these ecosystems are put and the effectiveness and cost-benefit aspect of any risk mitigation measures that may be applied.
951 citations
TL;DR: It is suggested that a small increase in estrogen may modulate the action of androgen in regulating prostate differentiation, resulting in a permanent increase in prostatic androgen receptors and prostate size.
Abstract: On the basis of results of studies using high doses of estrogens, exposure to estrogen during fetal life is known to inhibit prostate development. However, it is recognized in endocrinology that low concentrations of a hormone can stimulate a tissue, while high concentrations can have the opposite effect. We report here that a 50% increase in free-serum estradiol in male mouse fetuses (released by a maternal Silastic estradiol implant) induced a 40% increase in the number of developing prostatic glands during fetal life; subsequently, in adulthood, the number of prostatic androgen receptors per cell was permanently increased by 2-fold, and the prostate was enlarged by 30% (due to hyperplasia) relative to untreated males. However, as the free serum estradiol concentration in male fetuses was increased from 2- to 8-fold, adult prostate weight decreased relative to males exposed to the 50% increase in estradiol. As a model for fetal exposure to man-made estrogens, pregnant mice were fed diethylstilbestrol (DES) from gestation days 11 to 17. Relative to controls, DES doses of 0.02, 0.2, and 2.0 ng per g of body weight per day increased adult prostate weight, whereas a 200-ng-per-g dose decreased adult prostate weight in male offspring. Our findings suggest that a small increase in estrogen may modulate the action of androgen in regulating prostate differentiation, resulting in a permanent increase in prostatic androgen receptors and prostate size. For both estradiol and DES, prostate weight first increased then decreased with dose, resulting in an inverted-U dose-response relationship.
691 citations
TL;DR: In principle, it should be possible to develop selective aromatase modulators (SAMs) that block aromat enzyme expression in breast, but allow unimpaired estrogen synthesis in other tissues such as bone.
Abstract: There is growing awareness that androgens and estrogens have general metabolic roles that are not directly involved in reproductive processes. These include actions on vascular function, lipid and carbohydrate metabolism, as well as bone mineralization and epiphyseal closure in both sexes. In postmenopausal women, as in men, estrogen is no longer solely an endocrine factor but instead is produced in a number of extragonadal sites and acts locally at these sites in a paracrine and intracrine fashion. These sites include breast, bone, vasculature, and brain. Within these sites, aromatase action can generate high levels of estradiol locally without significantly affecting circulating levels. Circulating C19 steroid precursors are essential substrates for extragonadal estrogen synthesis. The levels of these androgenic precursors decline markedly with advancing age in women, possible from the mid-to-late reproductive years. This may be a fundamental reason why women are at increased risk for bone mineral loss and fracture, and possibly decline of cognitive function, compared with men. Aromatase expression in these various sites is under the control of tissue-specific promotors regulated by different cohorts of transcription factors. Thus in principle, it should be possible to develop selective aromatase modulators (SAMs) that block aromatase expression, for example, in breast, but allow unimpaired estrogen synthesis in other tissues such as bone.
688 citations